IRD FY 2024 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$349M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M-42.3% YoY

Gross Profit

$11M100.0% margin

Operating Income

-$62M-564.7% margin

Net Income

-$58M-523.4% margin

EPS (Diluted)

$-2.15

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$37M

Total Liabilities

$30M

Stockholders' Equity

$7M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$19M	-42.3%
Gross Profit	$11M	$19M	-42.3%
Operating Income	-$62M	-$11M	-487.7%
Net Income	-$58M	-$10M	-476.1%